Anatolia was established in Istanbul in 2010 by partners with decades of experience in molecular genetics, healthcare, mechanical engineering, and marketing. This interdisciplinary structure of the company is the key factor in creating solution-oriented and efficient products for people in a wide geography.
Our main expertise is designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, rapid antigen test kits, and automated nucleic acid extraction instruments. With the integration of Real-Time PCR instruments manufactured under its own brand, Anatolia is one of the very few companies in the world with the ability to create turnkey solutions for Real-Time PCR applications.
Anatolia Geneworks carries out its relevant operations in accordance with the ISO 9001:2015, ISO 13485:2016 standards, 98/79/EC directive, EU 2017/746 IVDR, and 2006/42/EC regulations. Anatolia became the first company in Türkiye to get IVDR certification for high-risk molecular diagnostic products.
Anatolia Tanı A.Ş. has an impressive R&D Center with highly advanced infrastructure and a high-quality multidisciplinary R&D team. As of 21st October 2021, Anatolia became a publicly listed company in the Istanbul Stock Exchange (BIST). Anatolia has subsidiaries abroad in Germany, the Netherlands, Italy, Poland, Bulgaria, Pakistan, and the Philippines.
The company’s primary goal is to achieve worldwide market success by developing and manufacturing high-quality molecular diagnostics products. Anatolia operates in the R&D and manufacturing laboratories and in the CNC workshops, which ultimately have an advanced infrastructure. The company guarantees high precision, sensitivity, reproducibility, performance, and quality of its products by stringent quality control procedures in compliance with the regulations and quality standards.